I think this is a rare opportunity and wouldn't want to miss a single share. Long term upside unreal. I think folks realize the enormous market and reality of Regenerative care, everyone benefits less drugs more natural process.
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.